Lombard Odier Asset Management (USA)’s Cymabay Therapeutics CBAY Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-145,000	Closed	-$284K	–	278
2019 Q4	$284K	Hold	145,000	–	–	0.03%	219
2019 Q3	$742K	Hold	145,000	–	–	0.07%	193
2019 Q2	$1.04M	Sell	145,000 -35,000	-19%	-$396K	0.08%	166
2019 Q1	$2.39M	Sell	180,000 -39,495	-18%	-$420K	0.2%	111
2018 Q4	$1.73M	Sell	219,495 -78,566	-26%	-$748K	0.14%	143
2018 Q3	$3.3M	Sell	298,061 -80,939	-21%	-$1.01M	0.24%	117
2018 Q2	$5.09M	Sell	379,000 -25,000	-6%	-$313K	0.33%	93
2018 Q1	$5.25M	Sell	404,000 -117,247	-22%	-$1.46M	0.38%	69
2017 Q4	$4.79M	Sell	521,247 -3,753	-0.7%	-$32.1K	0.37%	79
2017 Q3	$4.23M	Sell	525,000 -1,665	-0.3%	-$11.3K	0.3%	93
2017 Q2	$3.03M	Hold	526,665	–	–	0.24%	111
2017 Q1	$2.27M	Sell	526,665 -50,000	-9%	-$143K	0.21%	129
2016 Q4	$998K	Sell	576,665 -50,313	-8%	-$88.8K	0.13%	131
2016 Q3	$1.22M	Sell	626,978 -26,238	-4%	-$52.2K	0.11%	182
2016 Q2	$1.14M	Sell	653,216 -56,224	-8%	-$117K	0.14%	143
2016 Q1	$958K	Sell	709,440 -376,241	-35%	-$466K	0.13%	136
2015 Q4	$1.83M	Sell	1,085,681 -12,517	-1%	-$20.4K	0.18%	119
2015 Q3	$2.13M	Buy	1,098,198 +356,072	+48%	+$969K	0.19%	136
2015 Q2	$2M	Sell	742,126 -568,874	-43%	-$2.34M	0.14%	148
2015 Q1	$9.07M	Sell	1,311,000 -57,557	-4%	-$553K	0.72%	39
2014 Q4	$13.5M	Buy	1,368,557 +118,557	+9%	+$953K	0.92%	27
2014 Q3	$8.55M	Buy	+1,250,000	New	+$7.68M	0.59%	51

Other funds holding CBAY

ECM

Engine Capital Management New York $1.03B AUM 4.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s CBAY Position: Q1 2020 in Review

Lombard Odier Asset Management (USA) sold out of Cymabay Therapeutics (CBAY) in Q1 2020, closing a stake of 145,000 shares — an estimated $284K sold.

Lombard Odier Asset Management (USA) first reported a position in CBAY in Q3 2014 and held it in 22 quarters. The position peaked at $13.5M in Q4 2014. 102 funds tracked by Wall St. Rank hold CBAY as of Q1 2020.

Lombard Odier Asset Management (USA) reported no remaining Cymabay Therapeutics position as of Q1 2020 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 145,000 Cymabay Therapeutics shares in Q1 2020, an estimated $284K.
Lombard Odier Asset Management (USA) first reported a position in Cymabay Therapeutics in Q3 2014 and held it in 22 quarters.
Lombard Odier Asset Management (USA)'s Cymabay Therapeutics position peaked at $13.5M in Q4 2014.
102 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2020.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2020, filed 15 May 2020.